State Street Corporation 13D and 13G filings for Vanda Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-22 11:26 am Sale |
2023-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
STATE STREET CORP STT |
1,228,096 2.130% |
-2,499,702 (-67.06%) |
Filing |
| 2023-02-07 2:24 pm Purchase |
2022-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
STATE STREET CORP STT |
3,727,798 6.590% |
400,365 (+12.03%) |
Filing |
| 2022-02-11 9:12 pm Purchase |
2021-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
STATE STREET CORP STT |
3,327,433 5.970% |
123,529 (+3.86%) |
Filing |
| 2021-02-11 08:32 am Purchase |
2020-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
STATE STREET CORP STT |
3,203,904 5.860% |
3,203,904 (New Position) |
Filing |